Table 3.
Hazard Ratio (95% CI) | |||||
---|---|---|---|---|---|
|
|||||
Variable | Categories | Overall survival | p-value | Cancer specific survival | p-value |
Age | ±median | 1.88 (1.25–2.83) | 0.002 | 1.18 (0.69–2.00) | 0.56 |
T-stage | T1/2 vs. T3/4 | 2.63 (1.63–4.23) | <0.0001 | 4.30 (2.03–9.10) | <0.0001 |
N-stage | N0 vs. N1/2 | 1.59 (0.75–3.42) | 0.23 | 1.89 (0.83–4.32) | 0.13 |
M-stage | M0 vs. M1 | 3.43 (2.09–5.62) | <0.0001 | 4.58 (2.46–8.52) | <0.0001 |
Nuclear Grade | G1/2 vs. G3/4 | 0.98 (0.54–1.80) | 0.96 | 1.37 (0.69–2.73) | 0.37 |
Tumor Necrosis | yes vs. no | 1.23 (0.83–1.84) | 0.3 | 1.65 (0.94–2.90) | 0.08 |
Sarcomatoid Differentiation | yes vs. no | 1.63 (0.83–3.20) | 0.15 | 1.62 (1.68–3.45) | 0.16 |
β-catenin Score cytoplasm tumor | ±mean | 1.00 (0.55–1.84) | 0.99 | 0.88 (0.43–1.83) | 0.75 |